Amanote Research
Register
Sign In
Receptor Tyrosine Kinase (RTK); VEGF-A
Science-Business eXchange
doi 10.1038/scibx.2014.486
Full Text
Open PDF
Abstract
Available in
full text
Date
May 1, 2014
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
No One-Way Street: Cross-Talk Between E-Cadherin and Receptor Tyrosine Kinase (RTK) Signaling—A Mechanism to Regulate RTK Activity
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Receptor Tyrosine Kinase–like Orphan Receptor 1 (ROR1)
Science-Business eXchange
AXL Receptor Tyrosine Kinase (AXL; UFO)
Science-Business eXchange
Preclinical Overview of Sorafenib, a Multikinase Inhibitor That Targets Both Raf and VEGF and PDGF Receptor Tyrosine Kinase Signaling
Molecular Cancer Therapeutics
Cancer Research
Oncology
RYK, a Receptor Tyrosine Kinase-Related Molecule With Unusual Kinase Domain Motifs.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Tyrosine Kinase Non-Receptor 2 (Tnk2; ACK1)
Science-Business eXchange
Biological Function of Nuclear Receptor Tyrosine Kinase Action
Cold Spring Harbor perspectives in biology
Biochemistry
Genetics
Molecular Biology
Tyrosine Kinase Signalling in Breast Cancer: ErbB Family Receptor Tyrosine Kinases
Breast Cancer Research
Cancer Research
Oncology
The Neuronal Receptor Tyrosine Kinase Alk Is a Target for Longevity
Aging Cell
Aging
Cell Biology
